- Patient Resources
- Public Policy
- Resource Library
- Industry Partners
|Get to Know Your IRC Participants - Pathnostics|
Pathnostics is a diagnostic solutions company that pioneers innovative approaches for improved patient care. Leveraging its proprietary and patented technology, the company develops solutions that address diagnostic and therapeutic issues for home care medicine and their patients. Earlier this month, Pathnostics announced results from a new Institutional Review Board-approved, large-patient study revealing a 13.7 percent reduction in hospital admissions and emergency department (ED) visits from patients who were treated for urinary tract infections (UTIs) based on results from the company’s advanced Guidance® UTI test compared to those treated based on standard urine culture results. The results were published in JOJ Urology & Nephrology, an open access, peer-reviewed international journal. The study’s findings come at a time when the health care industry is focused more than ever on reducing hospital visits and admissions.
How is your company advancing home care medicine?
Pathnostics is advancing the Home Healthcare Industry by reducing the number of hospitalizations due to UTI’s. On April 15th, 2020 Pathnostics announced results from a new IRB approved, 60,000 patient study revealing a 13.7 percent reduction in Hospital and emergency department (ED) visits from patients who were treated for urinary tract infections. The study also revealed a savings greater than $10 million to that regions home healthcare system. These outcomes are based on results from the company’s advanced Guidance® UTI test compared to those treated based on standard urine culture. The results were published in JOJ Urology & Nephrology, an open access, peer-reviewed international journal. Please see link to our study.
What is something people may not know about your company?
With nearly 30 percent of all 4 million annual UTI cases ending up in a misdiagnoses, increasing numbers of physicians are turning to Pathnostics’ Guidance UTI test in lieu of traditional urine culture testing. What people may not know about our company is that since launching its Guidance UTI test in 2016, Pathnostics has performed nearly 200,000 patient tests on behalf of more than 750 providers.
Learn more about AAHCM's Industry Relations Council (IRC).
Interested in joining the IRC? For more information, please reach out to Stacy Warkentine at email@example.com.